The antifungal susceptibility of Candida albicans isolated from HIV/AIDS patients

• Autores principales: Sri Rezeki (Autor), Siti Aliyah Pradono (Autor), Gus Permana Subita (Autor), Yeva Rosana (Autor), S. Sunnati (Autor), Basri A. Gani (Autor)
• Formato: Libro
• Publicado: Universitas Airlangga, 2021-06-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background: Candida albicans was found to be dominant in patients with human immunodeficiency virus / acquired immunodeficiency syndrome (HIV/AIDS). The antifungals fluconazole, ketoconazole, and nystatin were used as oral candidiasis therapy for HIV/AIDS, each of which has differing susceptibility...